PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
The paper considers the joint management of rheumatoid arthritis patients needing endoprosthetic replacement of the large joints of the lower extremities by rheumatologists and orthopedic traumatologists.Due to the fact that there are no conventional standards or guidelines for the perioperative man...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2014-09-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1956 |
| _version_ | 1797862757085741056 |
|---|---|
| author | V. N. Amirdzhanova M. A. Makarov E. I. Byalik S. A. Makarov M. M. Lipina |
| author_facet | V. N. Amirdzhanova M. A. Makarov E. I. Byalik S. A. Makarov M. M. Lipina |
| author_sort | V. N. Amirdzhanova |
| collection | DOAJ |
| description | The paper considers the joint management of rheumatoid arthritis patients needing endoprosthetic replacement of the large joints of the lower extremities by rheumatologists and orthopedic traumatologists.Due to the fact that there are no conventional standards or guidelines for the perioperative management of patients with rheumatic diseases, adopted by international rheumatology associations, the authors generalize their experience in managing the patients in terms of international approaches and guidelines from different countries. The medical assessment and reduction of cardiovascular risks, the prevention of infectious complications, hemorrhages, and lower extremity deep vein thrombosis, and the specific features of management of patients with osteoporosis are under consideration. The authors' experience in managing the patients receiving antirheumatic therapy with nonsteroidal antiinflammatory and disease-modifying antirheumatic drugs, such as methotrexate, leflunomide, sulfasalazine, and hydroxychloroquine, is detailed. Recommendations for managing patients taking glucocorticoids and biologic agents (tumor necrosis factor-α inhibitors, anti-B-cell therapy, and interleukin-6 receptor inhibitors) in the preoperative andpostoperative periods are given. |
| first_indexed | 2024-04-09T22:24:45Z |
| format | Article |
| id | doaj.art-05e35599dc1343ec9ea90b1b4ebd80dc |
| institution | Directory Open Access Journal |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| last_indexed | 2024-04-09T22:24:45Z |
| publishDate | 2014-09-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj.art-05e35599dc1343ec9ea90b1b4ebd80dc2023-03-22T13:45:49ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-09-0152436637510.14412/1995-4484-2014-366-3751888PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITISV. N. Amirdzhanova0M. A. Makarov1E. I. Byalik2S. A. Makarov3M. M. Lipina4V.A. Nasonova Research Institute of Rheumatology, MoscowV.A. Nasonova Research Institute of Rheumatology, MoscowV.A. Nasonova Research Institute of Rheumatology, MoscowV.A. Nasonova Research Institute of Rheumatology, MoscowV.A. Nasonova Research Institute of Rheumatology, MoscowThe paper considers the joint management of rheumatoid arthritis patients needing endoprosthetic replacement of the large joints of the lower extremities by rheumatologists and orthopedic traumatologists.Due to the fact that there are no conventional standards or guidelines for the perioperative management of patients with rheumatic diseases, adopted by international rheumatology associations, the authors generalize their experience in managing the patients in terms of international approaches and guidelines from different countries. The medical assessment and reduction of cardiovascular risks, the prevention of infectious complications, hemorrhages, and lower extremity deep vein thrombosis, and the specific features of management of patients with osteoporosis are under consideration. The authors' experience in managing the patients receiving antirheumatic therapy with nonsteroidal antiinflammatory and disease-modifying antirheumatic drugs, such as methotrexate, leflunomide, sulfasalazine, and hydroxychloroquine, is detailed. Recommendations for managing patients taking glucocorticoids and biologic agents (tumor necrosis factor-α inhibitors, anti-B-cell therapy, and interleukin-6 receptor inhibitors) in the preoperative andpostoperative periods are given.https://rsp.mediar-press.net/rsp/article/view/1956rheumatoid arthritisendoprosthetic joint replacementdisease-modifying antirheumatic drugsgenetically engineered biological agents |
| spellingShingle | V. N. Amirdzhanova M. A. Makarov E. I. Byalik S. A. Makarov M. M. Lipina PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS Научно-практическая ревматология rheumatoid arthritis endoprosthetic joint replacement disease-modifying antirheumatic drugs genetically engineered biological agents |
| title | PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS |
| title_full | PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS |
| title_fullStr | PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS |
| title_full_unstemmed | PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS |
| title_short | PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS |
| title_sort | perioperative management of patients with rheumatoid arthritis |
| topic | rheumatoid arthritis endoprosthetic joint replacement disease-modifying antirheumatic drugs genetically engineered biological agents |
| url | https://rsp.mediar-press.net/rsp/article/view/1956 |
| work_keys_str_mv | AT vnamirdzhanova perioperativemanagementofpatientswithrheumatoidarthritis AT mamakarov perioperativemanagementofpatientswithrheumatoidarthritis AT eibyalik perioperativemanagementofpatientswithrheumatoidarthritis AT samakarov perioperativemanagementofpatientswithrheumatoidarthritis AT mmlipina perioperativemanagementofpatientswithrheumatoidarthritis |